🇪🇺 VORETIGENE NEPARVOVEC in European Union

VORETIGENE NEPARVOVEC (VORETIGENE NEPARVOVEC) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/004451
  • Local brand name: Luxturna
  • Status: approved

VORETIGENE NEPARVOVEC in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is VORETIGENE NEPARVOVEC approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for VORETIGENE NEPARVOVEC in European Union?

Marketing authorisation holder not available in our data.